Charterhouse Capital Partners Invests in PHASTAR
January 5, 2021
Charterhouse Capital Partners has made a growth investment in PHASTAR, a specialist biometrics clinical research organisation (CRO). PHASTAR founder Kevin Kane remains CEO and a significant shareholder; Charterhouse will support the company's geographic expansion and capability growth while Nick Edwards joins as non-executive chair.
- Buyers
- Charterhouse Capital Partners LLP
- Targets
- PHASTAR
- Industry
- Healthcare Services
- Location
- England, United Kingdom
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
Charterhouse Invests in Skin Tech Pharma Group
June 21, 2024
Medical Devices
Charterhouse Capital Partners has announced an investment in Skin Tech Pharma Group, a Spain-headquartered medical aesthetics manufacturer founded by Dr Philippe Deprez. The partnership will support Skin Tech’s organic growth (product innovation and market entry) and pursue inorganic expansion through targeted M&A while the founder is re-investing in the business.
-
Wavecrest Growth Partners and Abry Partners Make Growth Investment in Pole Star
April 7, 2021
Cloud & SaaS
Wavecrest Growth Partners and Abry Partners completed a growth investment in Pole Star Space Applications Limited to accelerate hiring, scale sales, and expand product development for its cloud-based maritime compliance, surveillance, and sustainability SaaS solutions. The capital will support commercialization and innovation into AI, ML and distributed ledger technologies as Pole Star pursues broader digitalisation across maritime trade, ports, and commodity finance markets.
-
Genstar Capital Acquires Majority Stake in Flourish Research
September 18, 2024
Healthcare Services
Genstar Capital has made a strategic majority investment in Flourish Research, a multi-site clinical trial organization headquartered in Apex, North Carolina. The transaction represents an exit for NMS Capital, which built Flourish into a 24-site network with ~150 investigators and scaled the business through infrastructure investments and acquisitions.
-
Kester Capital Acquires EMAS Pharma (carve-out from Bionical Emas)
December 24, 2024
Healthcare Services
Kester Capital has acquired EMAS Pharma, the clinical development division of Bionical Emas, in a carve-out transaction alongside an incoming executive team led by experienced CRO operators. The deal creates an independent CRO platform that Kester and the management team intend to scale organically and through acquisitions, expanding capabilities and geographic presence in North America and Europe.
-
SCF Partners Makes Additional Investment in Powerstar
June 11, 2023
Renewable Energy
SCF Partners has made an additional minority investment in Powerstar to support the company's continued growth in smart electrification and energy resilience solutions. As part of the transition, founder and majority shareholder Dr. Alex Mardapittas will step down from the chairmanship and board but will remain involved as a consultant.
-
Charterhouse Capital Partners Invests in Vermeg
December 18, 2020
Software
Charterhouse Capital Partners has acquired an equity stake in Vermeg from Crédit Mutuel Arkéa, investing alongside Vermeg's founder and management who retain a shareholding. The investment will support Vermeg's continued organic growth and buy-and-build strategy to expand its software and digitalisation offerings for banking, insurance and wealth-management clients globally.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.